A move toward value-based arrangements in pharmaceuticals is a positive step toward creating a more sustainable healthcare system – Value Meets Pharma. But this will require broader changes in pharmaceutical business models than many anticipate. Ensuring a medication’s maximal value is delivered requires interaction with a complex side of the healthcare system most pharma companies […]
